Inhibition of Akt Increases the Sensitivity of Acute Lymphoblastic Leukemia (ALL) to the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG)

被引：0
|
作者：
Du, Jianfeng [1 ]
DeSalvo, Joanna [1 ]
Muranen, Antti [1 ]
Moraes, Carlos T. [1 ]
Barredo, Julio C. [1 ,2 ]
机构：
[1] Univ Miami, Miller Sch Med, Miami, FL 33136 USA
[2] Sylvester Comprehens Canc Ctr, Miami, FL USA
来源：
BLOOD | 2010年 / 116卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1334 / 1335
页数：2
相关论文
共 50 条
  • [1] 2-Deoxy-D-Glucose (2-DG) as a glycolytic inhibitor in the treatment of retinoblastoma
    Decatur, Christina
    Pina, Yolanda
    Houston, Samuel
    Cayalcante, Ludimila
    Shah, Nikesh
    Murray, Timothy
    [J]. CANCER RESEARCH, 2011, 71
  • [2] Mechanisms of Sensitivity of B-Precursor, T-Lineage and BCR/ABL Positive Acute Lymphoblastic Leukemia (ALL) to the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG)
    Du, Jianfeng
    DeSalvo, Joanna
    Barredo, Julio C.
    [J]. BLOOD, 2009, 114 (22) : 1198 - 1198
  • [3] Activation of macrophages by the glycolytic inhibitor 2-deoxy-D-glucose (2-DG): Implications for tumor therapy
    Farooque, Abdullah
    Singh, Saurabh
    Verma, Amit
    Afrin, Farhat
    Adhikari, Jawahar
    Dwarakanath, Bilikere
    [J]. CANCER RESEARCH, 2009, 69
  • [4] INSULIN VERSUS 2-DEOXY-D-GLUCOSE - OR 2-DG OR NOT 2-DG - UNANSWERED QUESTION
    ISENBERG, JI
    [J]. GASTROENTEROLOGY, 1972, 63 (04) : 701 - &
  • [5] Characterization of the effect of 2-deoxy-D-glucose (2-DG) on the immune system
    Chou, SH
    Kojic, LD
    Messingham, KN
    Cunnick, JE
    [J]. BRAIN BEHAVIOR AND IMMUNITY, 1996, 10 (04) : 399 - 416
  • [6] Chronic Dietary Administration of the Glycolytic Inhibitor 2-Deoxy-D-Glucose (2-DG) Inhibits the Growth of Implanted Ehrlich's Ascites Tumor in Mice
    Singh, Saurabh
    Pandey, Sanjay
    Bhatt, Anant Narayan
    Chaudhary, Richa
    Bhuria, Vikas
    Kalra, Namita
    Soni, Ravi
    Roy, Bal Gangadhar
    Saluja, Daman
    Dwarakanath, Bilikere S.
    [J]. PLOS ONE, 2015, 10 (07):
  • [7] HYPOTHERMIA FOLLOWING 2-DEOXY-D-GLUCOSE (2-DG) INJECTION INTO SELECTED HYPOTHALAMIC SITES
    SHIRAISH.T
    MAGER, M
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 408 - 408
  • [8] Targeting inflammation induced carcinogenesis by dietary administration of 2-deoxy-D-glucose (2-DG)
    Pandey, S.
    Singh, S.
    Anang, V.
    Seth, S.
    Bhatt, A. N.
    Manda, K.
    Natarajan, K.
    Dwarakanath, B. S.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 54 : S21 - S21
  • [9] Optimization of Tumor Radiotherapy Part VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor ModelPart VI: Modification of Tumor Glucose Metabolism for Increasing the Bioavailability of 2-Deoxy-D-Glucose (2-DG) in a Mutine Tumor Model
    Rakesh Kumar Sharma
    Surender Singh
    Mahavir Degaonkar
    Partha Raghunathan
    Amarnath Maitra
    Viney Jain
    [J]. Strahlentherapie und Onkologie, 2000, 176 (3) : 135 - 143
  • [10] 2-Deoxy-D-glucose (2-DG) combination with ketogenic diet induces sedation and hypothermia in mice that becomes lethal
    Zielinski, Rafal
    Castillo, Moises Martinez
    Grybowski, Damian
    Grela, Krzysztof
    Cardenas-Zuniga, Roberto
    Fokt, Izabela
    Skora, Stanislaw
    Ramirez, Gerardo
    Priebe, Waldemar
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
12345